← Back to Search

Radiation Therapy

Radiotherapy for Keloids

Phase < 1
Recruiting
Research Sponsored by Albert Einstein College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Clinically diagnosed keloid
Surgical excision of keloid is either contraindicated or patient has declined treatment with surgical excision
Must not have
Prior RT to the area of interest that would result in overlap of radiation therapy fields
Females of childbearing age without a negative serum pregnancy test prior to initiation of RT or unwilling to use contraception prior to and during the radiation course
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will study if radiation therapy is a safe and effective treatment for keloids that cannot be removed by surgery. The study will measure if the keloids shrink or stop growing, if symptoms improve, and if quality of life gets better.

Who is the study for?
This trial is for adults with clinically diagnosed keloids where surgery isn't an option or has been declined. It's open to those who have had keloids return after resection, as long as the current one can't be removed or they choose not to have it surgically treated. Women must test negative for pregnancy and agree to use contraception.Check my eligibility
What is being tested?
The study is testing the safety and effectiveness of radiation therapy on keloids that haven’t been removed by surgery. The main goal is to check for any side effects within 10 weeks, while also looking at whether the keloid stops growing, shrinks, feels better symptomatically, and improves life quality.See study design
What are the potential side effects?
Potential side effects from radiation therapy may include skin irritation, changes in skin coloration, fatigue, localized hair loss around the treatment area, and a slight risk of secondary cancers due to exposure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a keloid.
Select...
Surgery for my keloid is not an option or I have chosen not to have it.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had radiation therapy before in the same area where it's now planned.
Select...
I am of childbearing age and will take a pregnancy test before radiation or use birth control during treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Toxicity of the radiation
Secondary outcome measures
Size of keloids

Trial Design

1Treatment groups
Experimental Treatment
Group I: Radiation therapy groupExperimental Treatment1 Intervention
Single-institution pilot study to evaluate the safety and efficacy of radiation therapy (RT) for the treatment of unresected keloids. The primary endpoint will be toxicity within 10 weeks of follow-up. Secondary endpoints will include cessation of growth or shrinkage of keloids, symptomatic response, and impact on quality of life.

Find a Location

Who is running the clinical trial?

Albert Einstein College of MedicineLead Sponsor
287 Previous Clinical Trials
11,856,821 Total Patients Enrolled

Media Library

Radiation therapy of unresected keloids (Radiation Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT04853433 — Phase < 1
Radiation Therapy for the Treatment of Keloids Research Study Groups: Radiation therapy group
Radiation Therapy for the Treatment of Keloids Clinical Trial 2023: Radiation therapy of unresected keloids Highlights & Side Effects. Trial Name: NCT04853433 — Phase < 1
Radiation therapy of unresected keloids (Radiation Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04853433 — Phase < 1
~2 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top